March 06, 2020

JANKOWSKI et al v. ZYDUS PHARMACEUTICALS USA, INC.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. June 01, 2022

    Zydus Defeats 209-Patient Suit Over Heart Pill Marketing

    Zydus Pharmaceuticals USA Inc. shed claims by 209 people alleging they or their loved ones were harmed by the off-label marketing of a generic heart medication, with a New Jersey federal judge rejecting arguments that the company had a duty to warn prescribing physicians about the drug's dangers.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS